The Hospital Universitario Fundación Alcorcón is a major general hospital in Alcorcón, a city in the Madrid metropolitan area of Spain. It was founded in 1997.

During the past decade, Hospital Universitario Fundación Alcorcón conducted 119 clinical trials. In the 10-year time frame, 119 clinical trials started and 55 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 32 clinical trials were completed. i.e. 59.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Fundación Alcorcón" #1 sponsor was "Pfizer" with 17 trials, followed by "Spanish Breast Cancer Research Group" with 12 trials sponsored, "PETHEMA Foundation" with 10 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored and "Fundacion SEIMC-GESIDA" with 7 trials sponsored. Other sponsors include 154 different institutions and companies that sponsored additional 111 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Fundación Alcorcón" #1 collaborator was "Pfizer" with 7 trials as a collaborator, "Hoffmann-La Roche" with 6 trials as a collaborator, "Hospital Universitario Fundación Alcorcón" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 5 trials as a collaborator and "Merck Sharp & Dohme LLC" with 5 trials as a collaborator. Other collaborators include 154 different institutions and companies that were collaborators in the rest 129 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Fundación Alcorcón" are "Breast Cancer" (17 trials), "Multiple Myeloma" (6 trials), "Psoriasis" (6 trials), "Non-Small Cell Lung Cancer" (5 trials) and "Chronic Hepatitis C" (4 trials). Many other conditions were trialed in "Hospital Universitario Fundación Alcorcón" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Fundación Alcorcón" are "Drug" (151 trials), "Other" (31 trials), "Procedure" (12 trials), "Biological" (10 trials) and "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (41 trials), "Paclitaxel" (8 trials), "Dexamethasone" (6 trials), "Cyclophosphamide" (5 trials) and "Lenalidomide" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Fundación Alcorcón" are 173 trials for "All" genders, 29 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Fundación Alcorcón". 1 are not yet recruiting, 32 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 127 completed trials in Hospital Universitario Fundación Alcorcón, 1 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Fundación Alcorcón, 3 "Phase 1" clinical trials were conducted, 49 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 23 trials, and there were also 13 trials that are defined as “Not Applicable".

Hospital Universitario Fundación Alcorcón has several departments that took part in Clinical trials: "Fundacion Hospital de Alcorcon; Servicio de Oncologia" - 4 trials, "Fundacion Hospital de Alcorcon; Servicio de Hematologia" - 2 trials